Robert Walters (RWA)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 132.00 |
|---|---|
| 52-week range | 76.00 – 165.50 |
| Return, 1 month / 3 months | −5.4% / +15.8% |
| Return, 1 year / 3 years | −14.6% / −58.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 58.7% |
| Worst drawdown (1 year) | -48.0% |
| Average daily value traded | 15.70M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Robert Walters is a recruitment consultancy based in London that helps employers find professional and specialist staff and helps candidates find permanent and contract roles. It works across fields such as accounting and finance, engineering, technology, legal and human resources, serving businesses of many sizes and job seekers at various career stages. The firm operates through a network of offices in the United Kingdom and overseas, matching people with roles in their local markets and internationally.
Robert Walters trades under the code RWA on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Robert Walters (RWA) trades on the London Exchange in UK. It last closed at GBX 132.00 on 23 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 1,445 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 14.6% and over the last three months it rose 15.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 76 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.1% | ||
| From 52-week high | -19.5% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 15.8% | ||
| 6-month return | 35.2% | ||
| 12-month return, skipping the last month | -9.7% | ||
| Stability (higher is calmer) | 21 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.0% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 15.70M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −5.4% |
| 3 months | +15.8% |
| 6 months | +35.2% |
| 1 year | −14.6% |
| 3 years | −58.2% |
| 5 years | −79.2% |
Signals
| 50-day / 200-day average | 135.23 / 110.82 |
|---|---|
| Golden / death cross (60 days) | Golden, 41 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 24 Apr 2025 | GBP 0.1700 |
| 29 Aug 2024 | GBP 0.0650 |
| 2 May 2024 | GBP 0.1700 |
| 31 Aug 2023 | GBP 0.0650 |
| 27 Apr 2023 | GBP 0.1700 |
| 1 Sep 2022 | GBP 0.0650 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.